These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5459028)

  • 1. Hypocholesteremic agents. I. Substituted stilbazoles and dihydrostilbazoles.
    Villani FJ; Ellis CA; Tavares RF; Steinberg M; Tolksdorf S
    J Med Chem; 1970 May; 13(3):359-66. PubMed ID: 5459028
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic formation and synthesis of 1-(3-chlorophenyl)-2(4-hydroxyphenyl)-1-methyl-2(2 pyridine)ethanol. A potential hypocholesteremic agent.
    Sinsheimer JE; Van den Eeckhout E; Hewitt LE; Kido Y; Wade DR; Hansen DW; Drach JC; Burckhalter JH
    J Med Chem; 1976 May; 19(5):647-50. PubMed ID: 1271406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-(2-Pyridine)benzyl aryl ketones as potential hypocholesteremic agents.
    Hewitt LE; Wade DR; Sinsheimer JE; Wang JH; Drach JC; Burckhalter JH
    J Med Chem; 1978 Dec; 21(12):1339-40. PubMed ID: 722749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesteremic agents. IV. Some substituted piperazines.
    Wright HB; Martin DL
    J Med Chem; 1968 Mar; 11(2):390-1. PubMed ID: 5663639
    [No Abstract]   [Full Text] [Related]  

  • 5. Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
    Kokosa JM; Sinsheimer JE; Wade DR; Drach JC; Burckhalter JH
    J Med Chem; 1978 Feb; 21(2):225-8. PubMed ID: 621720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New hypocholesteremic tertiary alcohols].
    Boissier JR; Ratouis R; Dumont C; Lesbros J; Lavaux JP
    Arzneimittelforschung; 1967 Sep; 17(9):1193-6. PubMed ID: 5632297
    [No Abstract]   [Full Text] [Related]  

  • 7. N-aralkyl-piperidyl carbanilates as hypocholesteremic agents.
    O'Brien DE; Rost WJ
    J Pharm Sci; 1970 Mar; 59(3):303-5. PubMed ID: 5416166
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on hypolipidemic agents. III. Syntheses and hypocholesteremic activities of morpholino and trifluoromethyl derivatives (author's transl)].
    Miyoshi F; Nagao K
    Yakugaku Zasshi; 1974 Aug; 94(8):1028-32. PubMed ID: 4472623
    [No Abstract]   [Full Text] [Related]  

  • 9. N-Aralkyl-N-methylaminoethyl carbanilates as hypocholesteremic agents.
    Rost WJ; Sutton BM; Blank B; Pfeiffer FR; Holmes WL; Ditullio NW; Ingram EB
    J Pharm Sci; 1967 Dec; 56(12):1598-603. PubMed ID: 5588711
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Sliskovic DR; Blankley CJ; Krause BR; Newton RS; Picard JA; Roark WH; Roth BD; Sekerke C; Shaw MK; Stanfield RL
    J Med Chem; 1992 May; 35(11):2095-103. PubMed ID: 1597859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of molecular modification on hypocholesteremic activity of 1,3-bis(substituted phenoxy)-2-propanones and related derivatives.
    Wyrick SD; Piantadosi C
    J Med Chem; 1978 Apr; 21(4):386-90. PubMed ID: 650666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal hypocholesteremic agents. II. The synthesis and serum sterol lowering properties of 4-(2'-dialkylaminoalkoxy)-4'-substituted biphenyls and related compounds.
    Bach FL; Barclay JC; Kende F; Cohen E
    J Med Chem; 1968 Sep; 11(5):987-93. PubMed ID: 5697112
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypocholesterolemic 5-substituted tetrazoles.
    Buchanan RL; Sprancmanis V; Partyka RA
    J Med Chem; 1969 Nov; 12(6):1001-6. PubMed ID: 5351438
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonsteroidal hypocholesteremic agents. I. The synthesis and serum sterol lowering properties of substituted 4-(2-dialkylaminoethoxy)diphenylamines and related compounds.
    Bach FL; Barclay JC; Cohen E
    J Med Chem; 1967 Sep; 10(5):802-6. PubMed ID: 6048485
    [No Abstract]   [Full Text] [Related]  

  • 15. SOME HYPOCHOLESTEREMIC 2,3-DIPHENYLACRYLONITRILES.
    HUGHES GM; MOORE PF; STEBBINS RB
    J Med Chem; 1964 Jul; 7():511-8. PubMed ID: 14221137
    [No Abstract]   [Full Text] [Related]  

  • 16. HYPOCHOLESTEREMIC AGENTS. I. PYRIDYL CARBINOLS.
    WRIGHT HB; DUNNIGAN DA; BIERMACHER U
    J Med Chem; 1964 Jan; 7():113-5. PubMed ID: 14186010
    [No Abstract]   [Full Text] [Related]  

  • 17. Cycloalkanones. 3. Structure-activity relationships of hypocholesterolemic cyclooctanone derivatives.
    Carlson GL; Hall IH; Abernethy GS; Piantadosi C
    J Med Chem; 1974 Feb; 17(2):154-7. PubMed ID: 4809249
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyrolysis of 16-methylene 17-oxygenated-20-keto steroids. IV. Synthesis of 3-hydroxy-1,3,5(10)-estratrieno[17,16-c]-2'-methylfuran.
    Popper TL; Gmoj O; Carlon FE; Steinberg M
    J Med Chem; 1970 May; 13(3):564-5. PubMed ID: 5459039
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypocholesteremic agents. 2. Cyclohexane and indan derivatives.
    Villani FJ; Ellis CA
    J Med Chem; 1970 Nov; 13(6):1245-6. PubMed ID: 5479882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis, structure, and biological properties of some 8alpha-analogues of steroid estrogens with fluorine in position 2].
    Belov VN; Dudkin VIu; Urusova EA; Starova GL; Selivanov SI; Nikolaev SV; Eshchenko ND; Morozkina SN; Shavva AG
    Bioorg Khim; 2007; 33(3):315-23. PubMed ID: 17682387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.